1. |
Development WNT signaling pathway.Part 1. Degradation of beta-catenin in the absence WNT signaling |
1.231E−02 |
2. |
Action of GSK3 β in bipolar disorder |
1.231E−02 |
3. |
Cytoskeleton remodeling TGF, WNT, and cytoskeletal remodeling |
1.231E−02 |
4. |
Signal transduction PTEN pathway |
2.498E−02 |
5. |
Immune response NFAT in immune response |
2.498E−02 |
6. |
Development WNT signaling pathway. Part 2 |
2.50E−02 |
7. |
PGE2 pathways in cancer |
2.50E−02 |
8. |
Immune response CD28 signaling |
2.50E−02 |
9. |
Ligand-independent activation of androgen receptor in prostate cancer |
2.92E−02 |
10. |
Signal transduction mTORC2 downstream signaling |
2.92E−02 |